Search Mailing List Archives

Limit search to: Subject & Body Subject Author
Sort by: Reverse Sort
Limit to: All This Week Last Week This Month Last Month
Select Date Range     through    

[protege-discussion] REMINDER: NCBO Webinar Series, April 21 - Bron Kisler, CDISC SHARE – Pathway into the Future for Standards Development and Delivery

Trish Whetzel plwhetzel at
Tue Apr 20 06:17:27 PDT 2010

The next NCBO Webinar will be held TOMORROW, Wednesday, April 21, at 10am
PT. Please note there will not be a VOIP option, and attendees must call
into the teleconference.

Below is information on how to join the online meeting via WebEx and
accompanying teleconference. The Webinar will be presented by Mr. Bron
Kisler, Senior Director, Terminology and Strategic Alliances from the
Clinical Data Interchange Standards Consortium (CDISC). The title of the
presentation is "CDISC SHARE – Pathway into the Future for Standards
Development and Delivery".

For a schedule of the 2010 presentations or for more information about the
NCBO Seminar Series, see:

CDISC SHARE – Pathway into the Future for Standards Development and Delivery

Over the past decade, CDISC has fulfilled its mission by publishing and
supporting a suite of standards across the research study lifecycle and data
chain from collection (CDASH standard) through regulatory submission (SDTM
standard) and analysis (ADaM standard).  More recently, these standards have
been complemented and further aligned through standard controlled
terminology hosted by the National Cancer Institute.  As global adoption of
these standards increases, CDISC wishes to build on this success by
providing a “1-stop shopping” environment where CDISC data models, standard
data elements and controlled terminology can be aligned, linked and
published for electronic access and download. This environment, known as
CDISC SHARE, is envisioned as a globally accessible electronic library,
which through advanced technology, enables precise and standardized data
element definitions to be used by applications and studies to improve
biomedical research and its link with healthcare.

A detailed stakeholder analysis revealed that CDISC SHARE will reduce
barriers to adoption, enabling organizations to consistently implement a
single reference standard across the organization. The creation of a library
of shared semantics will enable CDISC stakeholders – global
biopharmaceutical companies, academic institutions and clinical research
organizations – to achieve multiple benefits including improved operational
efficiency around the collection, processing, exchanging and reporting of
data, evaluation of drug safety concerns across traditional organizational
boundaries, and, in the end, enhanced scientific capabilities and resulting
patient benefits and therapeutic efficacies.

In parallel with the development of SHARE, CDISC is optimizing its standards
development processes in order to develop and deliver new standards and
disease-specific content more quickly. When CDISC SHARE goes live in late
2010, these new standards will be loaded and aligned with existing

Regarding this new multi-dimensional metadata driven approach to standards
development, this presentation describes:

-CDISC SHARE Project Background
-Development Partners
-Current Status and Next Steps
-Overview of Disease Projects
-Steps to Accelerate and Improve Standards Development

Biographical Sketch:

Mr. Kisler has nearly 25-years of technical and business experience from
both the public and private sectors.  He has worked in the pharmaceutical
industry for 15-years, focusing on development of innovative clinical
research and healthcare solutions.

He co-founded several industry organizations including the Clinical Data
Interchange Standards Consortium (CDISC), where he currently serves as
Senior Director, Terminology and Strategic Alliances.  Mr. Kisler
spearheaded the CDISC Terminology Program in 2005 and has led the
development, harmonization and publication of controlled terminology
standards for clinical research.  Within this role he developed key
terminology partnerships and most notably with the National Cancer Institute
(NCI). Mr. Kisler also manages collaborations with the US FDA, the European
Medicines Agency and other global standards development organizations. He
serves as CDISC co-lead for ISO-JIC (Joint Initiative Council) projects for
which CDISC is a recognized liaison organization.

In partnership with Duke University, Mr. Kisler facilitated development of
therapeutic area data standards for Tuberculosis and Acute Coronary Syndrome
under the NIH Roadmap Program. These became a springboard for new projects
around Kidney Disease, Cardiovascular Disease, and Neurological Disorders.
These projects serve as a nexus for collaboration between the clinical
community, standards experts, Federal Agencies and other key stakeholder
organizations – Academic Medical Centers, Foundations, Professional
Societies and industry organizations.

Mr. Kisler is a graduate of the University of Central Florida in Orlando and
holds 3 Bachelor of Science degrees in Mathematics, Computer Science and

WEBEX Details:

Topic: NCBO Webinar Series
Date: Wednesday, April 21, 2010
Time: 10:00 am, Pacific Daylight Time (San Francisco, GMT-07:00)
Meeting Number: 929 613 752
Meeting Password: ncbomeeting

To join the online meeting (Now from iPhones too!)
1. Go to
2. Enter your name and email address.
3. Enter the meeting password: ncbomeeting
4. Click "Join Now".
5. Follow the instructions that appear on your screen.

To view in other time zones or languages, please click the link:

To join the audio conference only
Call-in toll number (US/Canada): 1-650-429-3300
Global call-in numbers:

Access code:929 613 752

For assistance
1. Go to
2. On the left navigation bar, click "Support".

Trish Whetzel, PhD
Outreach Coordinator
The National Center for Biomedical Ontology
Ph: 650-721-2378
whetzel at

NCBO-PublicTalks mailing list
NCBO-PublicTalks at
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <>

More information about the protege-discussion mailing list